1. Home
  2. LEDS vs IBIO Comparison

LEDS vs IBIO Comparison

Compare LEDS & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$1.45

Market Cap

12.3M

Sector

Technology

ML Signal

HOLD

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$2.67

Market Cap

50.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEDS
IBIO
Founded
2005
2008
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
50.4M
IPO Year
2010
2009

Fundamental Metrics

Financial Performance
Metric
LEDS
IBIO
Price
$1.45
$2.67
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
7.4K
1.1M
Earning Date
05-04-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
53.12
73.08
EPS
N/A
N/A
Revenue
$43,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.41
$0.56
52 Week High
$3.37
$6.89

Technical Indicators

Market Signals
Indicator
LEDS
IBIO
Relative Strength Index (RSI) 28.19 57.30
Support Level $1.41 $2.02
Resistance Level $1.63 $2.89
Average True Range (ATR) 0.06 0.24
MACD -0.00 0.03
Stochastic Oscillator 11.91 57.92

Price Performance

Historical Comparison
LEDS
IBIO

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: